Binuo Health CEO Xin Quanyu told VCBeat that following the cooperation agreement reached with Shenzhen Hui Investment Capital in July this year, which secured over RMB 500 million in directed fund support, the company has successively signed contracts with more than 60 partners to jointly build service centers and service stations. In August, Binuo Health officially launched the “Mingwo Health Service System,” introducing a comprehensive suite of products for human health risk management, including genetic screening, early disease screening, and health constitution assessment. Meanwhile, according to Xin Quanyu, Binuo Health will release its “Medicine and Food Homology” system in September and continue to roll out various health products in the coming months. These include a series of health products targeting chronic diseases such as hypertension and cardiovascular and cerebrovascular conditions for middle-aged and elderly individuals, as well as eye health management solutions for childhood myopia.
Behind the seemingly seamless and smooth sailing of fund support and product advancement lies the solid scientific team of Bainuo Health and its underlying core technology platform, “Bainuo Health Intelligent Brain.” Bainuo Health is a subsidiary of Bainuo International Life Science & Technology. The core team of Bainuo International Life Science & Technology has accumulated years of technical expertise in artificial intelligence, big data, and gene technology, achieving significant breakthroughs in research and development. It has established a comprehensive presence in the healthcare sector through four major systems: health education, health management, precision medicine, and intelligent Traditional Chinese Medicine (TCM). Bainuo Health serves as a crucial component of Bainuo International Life Science & Technology’s strategic entry into the health management field.
The core of Bainuo Health is “Mingwo,” an AI-powered personal physician. By continuously collecting users’ dynamic data across various dimensions and scenarios and consolidating it into a digital life account, “Mingwo” leverages AI-driven learning to gain deeper insights into each user. This process enriches the user’s digital life account, ultimately enabling the delivery of more precise and effective health management solutions.
The core underlying technology of “Mingwo” is the HealthAI Intelligent Health Brain. Xin Quanyu introduced, “The HealthAI Intelligent Health Brain primarily encompasses four key components: health data acquisition, health status assessment, health plan design, and health plan implementation. Specifically, it first collects health data across five major dimensions—genetics, proteomics, gut microbiota, Western medicine, and Traditional Chinese Medicine. Leveraging technologies such as big data, artificial intelligence, and natural language processing, the system performs deep learning and cognitive evolution to build a specialized foundational knowledge base. This knowledge base is then applied to conduct health risk assessments, design personalized health plans, and facilitate their execution, thereby creating a closed-loop system for health management.”
The construction of the HealthAI intelligent health knowledge system stems from two key pillars. First, its parent company, Bainuo International Life Sciences, has accumulated years of expertise in precision medicine, amassing precise medication data related to targeted therapy for tens of thousands of cancer patients, along with data on traditional Chinese medicinal diet-based rehabilitation. Second, Bainuo Health’s core team brings together experts in artificial intelligence, internet big data, biomedical science, health management, clinical medicine, and seasoned professionals in healthcare industry operations. Through collaboration between these expert teams and research institutions, hospitals, and other partners, a comprehensive and professional foundational knowledge base has been jointly developed, laying the groundwork for the entire “Mingwo” service system.
Leveraging the HealthAI intelligent health brain, Bainuo Health has further launched four applications: Mingwo Super Personal Doctor, Mingwo Health Service Platform, Mingwo Health+ Platform, and Mingwo Health Service Station.
Among these, the Mingwo Super Personal Doctor provides users with risk assessments for over 100 diseases by conducting a comprehensive evaluation of eight major physiological systems: digestive, endocrine, respiratory, immune, neuromuscular, urinary, reproductive, and circulatory. Furthermore, leveraging user medical records, test results, and smart device data, Mingwo constructs a personalized Digital Life Account. Through comprehensive analysis of this account’s data, it offers health recommendations across six dimensions: genetic screening, diet, rehabilitation management, physical examinations, exercise, and sleep. Users can monitor their health status and receive real-time health management plans via the “Mingwo” app.
The Mingwo Health Service Platform is a key vehicle for Binuo Health to promote its health products. Binuo Health has developed a comprehensive and systematic plan for the promotion of health products on this platform. The first phase involves establishing the “Health Risk Products” system. Xin Quanyu stated that with the company’s official launch of its full range of health risk management products, the construction of the first-phase system has been basically completed. The second phase focuses on building the “Medicine and Food Homology” system. Xin Quanyu added, “Medicated diets offer significant health-regulating benefits for the vast majority of users.” Binuo Health expects to roll out the related product lines sequentially starting in September. The third phase entails developing a functional product system, comprising health products or solutions targeted at specific conditions such as ophthalmic disorders, cardiovascular and cerebrovascular diseases, and diabetes. According to Xin Quanyu, the company will introduce nearly 100 health risk management products and several hundred products under the medicine and food homology system, with the entire Binuo Health service ecosystem expected to comprise over 1,000 products.
Mingwo Health Service Stations are the offline health management platforms of Bainuo Health. These stations integrate numerous elements of the Mingwo Health service system, including private physicians and a health service platform, to provide accessible health management services for community residents who are in a sub-health state, suffer from chronic diseases, or are elderly. “The service station is an aggregated terminal and a site where online services are implemented offline,” stated Xin Quanyu. For instance, the service stations consolidate service resources such as pharmacies, medical examination centers, restaurants, traditional Chinese medicine clinics, rehabilitation centers, and gyms, aiming to ensure the comprehensive implementation of health management.
The Mingwo Health+ Platform is an empowerment solution provided by Bainuo Health to B-end clients across various industries, such as physical examination centers and fruit stores. Tailored to the specific characteristics of each industry, it delivers customized health empowerment strategies. By providing cutting-edge equipment, AI technology, and appropriate health management solutions, the platform drives the health-oriented transformation and upgrading of B-end users.

Bainuo Health Online and Offline Platforms
Currently, Bainuo Health has established nearly 100 service centers or stations in southern China, including Guangdong, Guangxi, Hunan, Hubei, and Hong Kong, and is gradually expanding northward. It is expected to deploy approximately 500 service centers nationwide this year. Meanwhile, Bainuo Health is recruiting partners across China to jointly build health service centers and stations, establish a national health service network, and deliver superior health services to households throughout the country.